Fesoterodine on Urgency Episodes in Parkinson's Disease Population

NCT02385500 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Insufficient or untimely patient recruitment

Conditions

Urinary Bladder, Overactive
Parkinson Disease

Interventions

DRUG: Fesoterodine
DRUG: Placebo

Sponsor

Sir Mortimer B. Davis - Jewish General Hospital